Regular Article
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders

https://doi.org/10.1006/scdb.2001.0290Get rights and content

Abstract

Vascular endothelial growth factor (VEGF) was originally discovered as an endothelial-specific growth factor. While the predominant role of this growth factor in the formation of new blood vessels (angiogenesis) is unquestioned, recent observations indicate that VEGF also has direct effects on neurons and glial cells, and stimulates their growth, survival and axonal outgrowth. Because of these pleiotropic effects, VEGF has now been implicated in several neurological disorders both in the preterm infant (leukomalacia) and the adult (stroke, neurodegeneration, cerebral and spinal trauma, ischemic and diabetic neuropathy, nerve regeneration). A challenge for the future is to unravel to what extent the effect of VEGF in these disorders relates to its angiogenic activity or direct neurotrophic effect.

References (110)

  • PC Wong et al.

    An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

    Neuron

    (1995)
  • LI Bruijn

    ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions

    Neuron

    (1997)
  • MC Dal Canto et al.

    Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)

    Brain Res

    (1995)
  • JP Julien

    Amyotrophic lateral sclerosis unfolding the toxicity of the misfolded

    Cell

    (2001)
  • DW Cleveland

    From Charcot to SOD1: mechanisms of selective motor neuron death in ALS

    Neuron

    (1999)
  • N Shibata et al.

    Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients

    Brain Res

    (2001)
  • H Warita et al.

    Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice

    Brain Res Mol Brain Res

    (2001)
  • R Ochiai-Kanai et al.

    Immunohistochemical nitrotyrosine distribution in neonatal rat cerebrocortical slices during and after hypoxia

    Brain Res

    (1999)
  • A Rivard et al.

    Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity

    J Biol Chem

    (2000)
  • M Kobari et al.

    Local cerebral blood flow in motor neuron disease: correlation with clinical findings

    J Neurol Sci

    (1996)
  • G Waldemar et al.

    Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d, 1-HMPAO SPECT study

    J Neurol Sci

    (1992)
  • S Soker et al.

    Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

    Cell

    (1998)
  • T Takahashi et al.

    Plexin-neuropilin-1 complexes from functional semaphorin-3A receptors

    Cell

    (1999)
  • L Tamagnone

    Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates

    Cell

    (1999)
  • CL Lin et al.

    Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

    Neuron

    (1998)
  • JC de la Torre et al.

    Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide

    Brain Res Brain Res Rev

    (2000)
  • RN Kalaria et al.

    Vascular endothelial growth factor in Alzheimer’s disease and experimental cerebral ischemia

    Brain Res Mol Brain Res

    (1998)
  • CS Cobbs et al.

    Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat

    Neurosci Lett

    (1998)
  • M Detmar et al.

    Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

    J Invest Dermatol

    (1998)
  • HJ Marti et al.

    Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia

    Am J Pathol

    (2000)
  • JM Krum et al.

    VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS

    Exp Neurol

    (1998)
  • AJ Boulton et al.

    Diabetic neuropathy

    Med Clin North Am

    (1998)
  • DR Senger et al.

    Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

    Science

    (1983)
  • N Ferrara et al.

    Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

    Nature

    (1996)
  • P Carmeliet

    Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

    Nature

    (1996)
  • N Ferrara

    Role of vascular endothelial growth factor in regulation of physiological angiogenesis

    Am J Physiol Cell Physiol

    (2001)
  • G Neufeld et al.

    Vascular endothelial growth factor (VEGF) and its receptors

    FASEB J

    (1999)
  • M Shibuya et al.

    Structure and function of vascular endothelial growth factor receptor-1 and -2

    Curr Top Microbiol Immunol

    (1999)
  • MG Persico et al.

    Structure, expression and receptor-binding properties of placenta growth factor (PlGF)

    Curr Top Microbiol Immunol

    (1999)
  • S Hiratsuka et al.

    Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

    Proc Natl Acad Sci USA

    (1998)
  • DE Clark et al.

    A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation

    Biol Reprod

    (1998)
  • P Carmeliet

    Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    Nat Med

    (2001)
  • S Hiratsuka et al.

    Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis

    Cancer Res

    (2001)
  • CJ Robinson et al.

    The splice variants of vascular endothelial growth factor (VEGF) and their receptors

    J Cell Sci

    (2001)
  • HQ Miao et al.

    Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165

    J Cell Biol

    (1999)
  • M Tessier-Lavigne et al.

    The molecular biology of axon guidance

    Science

    (1996)
  • A Schultz et al.

    Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation

    Circulation

    (1999)
  • G Breier et al.

    Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development

    Dev Dyn

    (1995)
  • KH Plate

    Mechanisms of angiogenesis in the brain

    J Neuropathol Exp Neurol

    (1999)
  • DB Wang et al.

    Development and remodeling of cerebral blood vessels and their flow in postnatal mice observed with in vivo videomicroscopy

    J Cereb Blood Flow Metab

    (1992)
  • Cited by (0)

    1

    Corresponding author. Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Onderwijs en Navorsing, Herestraat 49, B-3000 Leuven, Belgium. [email protected]

    View full text